SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7580"If it's an ISO exercise you can't hold because then you get bittenRocky9-6/6/2004
7579<i>My problem is with the number of shares retained after exercise</i&gBiomaven-6/6/2004
7578"I'm sure he's the only one among sepr mgt that retains options forRocky9-6/4/2004
7577:-) JD must be phased and phonfused. Continual reloading of options they mayrkrw-6/4/2004
7576<i>On 1st review the management exercise and sales gives one little confidDavid C. Burns-6/4/2004
7575On 1st review the management exercise and sales gives one little confidence. Upojayhawk969-6/4/2004
7574A new thread for disgruntled biotech investors Subject 54984Edscharp-6/4/2004
7573>>>>>Rebuttal by TB - talked about need to keep employees in 'rkrw-6/4/2004
7572Quack + waddle + swim = duck Fred, you have had the makings of a cynic from youHarold Engstrom-6/3/2004
7571Hanging around SI, I've become MUCH more cynical than I used to be. And I wofred hayes-6/3/2004
7570Normally, I'd agree with you. But this is one management team which no longMichael Young-6/3/2004
7569Isn't SEPR supposedly about to launch a hugely successful product (Estorra) Harold Engstrom-6/3/2004
7568Yes but that 1.5 million shares sold by insiders in the last 6 months doesn'sjemmeri-6/3/2004
7567finance.yahoo.com In May these guys sold like crazy.Harold Engstrom-6/3/2004
7566<b>Two Studies, Two Results, and a Debate Over a Drug</b> By BARRY MDavid C. Burns-6/3/2004
7565Press Release Source: GlaxoSmithKline; The Restless Legs Syndrome Foundation RBiomaven-5/25/2004
7564<i> Int Arch Allergy Immunol. 2004 Apr;133(4):380-8. Epub 2004 Mar 17. RelBiomaven-5/25/2004
7563<b>Insiders Are Selling Like It's 1999</b> By ERIC DASH and DAVIDavid C. Burns-5/24/2004
7562But in the never-never world of corporations, the salaries and bonuses are not trkrw-5/23/2004
7561BTW, there was the following interesting breakdown in the 10-Q: <i> BeloBiomaven-5/23/2004
7560Although Xopenex is an approved drug, the MDI form raises many questions of dosiBiomaven-5/23/2004
7559"And further, where were TB, DS, O'Shea and other top brass going to goRocky9-5/23/2004
7558I can't shed much light. The comment was made in response to a question aboRocky9-5/23/2004
7557<i>Since X is already an approved drug, why should the mere addition of anjayhawk969-5/23/2004
7556Since X is already an approved drug, why should the mere addition of an MDI deviquidditch-5/22/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):